Paper · 2026 · Open access

SERUM MAGNESIUM AS AN INDEPENDENT PREDICTOR OF INSULIN RESISTANCE IN EARLY CHRONIC KIDNEY DISEASE

Dr. SANTOSH KUMAR, BELLA DAYO, Babeeta Hinduja, Asma Naveed, Fahad Nasim, SASSI KANWAL

Zenodo (CERN European Organization for Nuclear Research) · Published 23 February 2026 · DOI 10.5281/zenodo.18846884

Read the free full textCite this paper

In brief

“SERUM MAGNESIUM AS AN INDEPENDENT PREDICTOR OF INSULIN RESISTANCE IN EARLY CHRONIC KIDNEY DISEASE” is a 2026 paper by Dr. SANTOSH KUMAR and 5 co-authors, published in Zenodo (CERN European Organization for Nuclear Research). OpenAlex counts 0 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at Zenodo (CERN European Organization for Nuclear Research).

Citations
0
Authors
6

Abstract

Objective: To evaluate serum magnesium levels in patients with early chronic kidney disease (CKD) and determine whether magnesium independently predicts insulin resistance. Methods: This analytical cross-sectional study was conducted at Jinnah Postgraduate Medical Centre (JPMC), Karachi, from January to August 2025. A total of 180 adults with CKD stages 1–3 were enrolled through consecutive sampling. Fasting blood samples were analyzed for serum magnesium, fasting glucose, insulin, creatinine, and HbA1c. Estimated glomerular filtration rate (eGFR) was calculated using the CKD-EPI equation. Insulin resistance was assessed using the Homeostasis Model Assessment of Insulin Resistance (HOMA-IR). Intergroup comparisons were performed using one-way ANOVA, and associations were assessed using Pearson correlation and multivariate linear regression analysis. Results: Serum magnesium levels declined significantly with advancing CKD stage (2.12±0.21 mg/dL in stage 1, 1.98±0.19 in stage 2, and 1.82±0.17 in stage 3; p<0.001). In contrast, HOMA-IR increased progressively (2.1±0.8, 2.8±1.1, and 3.6±1.3, respectively; p<0.001). Serum magnesium showed a significant inverse correlation with HOMA-IR (r = −0.52, p<0.001) and fasting insulin (r = −0.49, p<0.001), and a positive correlation with eGFR (r = 0.45, p<0.001). After adjustment for age, BMI, HbA1c, and eGFR, serum magnesium remained an independent predictor of insulin resistance (β = −0.38, p<0.001). Conclusion: Lower serum magnesium levels are independently associated with increased insulin resistance in early CKD. Magnesium may serve as a useful metabolic marker and potential therapeutic target in this population.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

KUMAR, D. S., DAYO, B., Hinduja, B., Naveed, A., Nasim, F., & KANWAL, S. (2026). SERUM MAGNESIUM AS AN INDEPENDENT PREDICTOR OF INSULIN RESISTANCE IN EARLY CHRONIC KIDNEY DISEASE. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.18846884

MLA 9

KUMAR, Dr. SANTOSH, et al. “SERUM MAGNESIUM AS AN INDEPENDENT PREDICTOR OF INSULIN RESISTANCE IN EARLY CHRONIC KIDNEY DISEASE.” Zenodo (CERN European Organization for Nuclear Research), 2026. https://doi.org/10.5281/zenodo.18846884.

Chicago

KUMAR, Dr. SANTOSH, BELLA DAYO, Babeeta Hinduja, Asma Naveed, Fahad Nasim, and SASSI KANWAL. 2026. “SERUM MAGNESIUM AS AN INDEPENDENT PREDICTOR OF INSULIN RESISTANCE IN EARLY CHRONIC KIDNEY DISEASE.” Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.18846884.

Harvard

KUMAR, D. S. et al. (2026) ‘SERUM MAGNESIUM AS AN INDEPENDENT PREDICTOR OF INSULIN RESISTANCE IN EARLY CHRONIC KIDNEY DISEASE’, Zenodo (CERN European Organization for Nuclear Research). doi:10.5281/zenodo.18846884.

IEEE

D. S. KUMAR, B. DAYO, B. Hinduja, A. Naveed, F. Nasim, and S. KANWAL, “SERUM MAGNESIUM AS AN INDEPENDENT PREDICTOR OF INSULIN RESISTANCE IN EARLY CHRONIC KIDNEY DISEASE,” Zenodo (CERN European Organization for Nuclear Research), 2026, doi: 10.5281/zenodo.18846884.

BibTeX

@article{kumar2026serum,
  title     = {{SERUM MAGNESIUM AS AN INDEPENDENT PREDICTOR OF INSULIN RESISTANCE IN EARLY CHRONIC KIDNEY DISEASE}},
  author    = {KUMAR, Dr. SANTOSH and DAYO, BELLA and Hinduja, Babeeta and Naveed, Asma and Nasim, Fahad and KANWAL, SASSI},
  journal   = {Zenodo (CERN European Organization for Nuclear Research)},
  year      = {2026},
  doi       = {10.5281/zenodo.18846884},
  url       = {https://doi.org/10.5281/zenodo.18846884}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Nursing › Nutrition and Dietetics › Magnesium in Health and Disease

  • serum magnesium
  • insulin resistance
  • early chronic kidney disease
  • HOMA-IR
  • estimated glomerular filtration rate
  • CKD stage
  • fasting insulin
  • metabolic biomarkers

Work with this paper

Most-cited papers in Nursing

All highly cited Nursing papers

Questions about this paper

How do I cite this paper in APA style?

KUMAR, D. S., DAYO, B., Hinduja, B., Naveed, A., Nasim, F., & KANWAL, S. (2026). SERUM MAGNESIUM AS AN INDEPENDENT PREDICTOR OF INSULIN RESISTANCE IN EARLY CHRONIC KIDNEY DISEASE. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.18846884

How many times has this paper been cited?

0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Zenodo (CERN European Organization for Nuclear Research).

Who wrote this paper?

Dr. SANTOSH KUMAR, BELLA DAYO, Babeeta Hinduja, Asma Naveed, Fahad Nasim, SASSI KANWAL.

What is the DOI of this paper?

10.5281/zenodo.18846884. The permanent link is https://doi.org/10.5281/zenodo.18846884.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.